Reprint

Genetic Complexity of Hormone Sensitive Cancers

Edited by
April 2023
188 pages
  • ISBN978-3-0365-7116-4 (Hardback)
  • ISBN978-3-0365-7117-1 (PDF)

This is a Reprint of the Special Issue Genetic Complexity of Hormone Sensitive Cancers that was published in

Biology & Life Sciences
Summary

In this Special Issue, authors from nine countries on five continents provide overviews on and insights into current research topics related to the ‘Genetic Complexity of Hormone-Sensitive Cancers’. The chapters cover topics on completely novel technologies and instruments revolutionizing our view of biological entities, and also, novel extensions and revisions of existing and well-established technologies such as genetic probes and bar-coding techniques, which add a new dimension to microscopy, as they allow us to visualize DNA sequences and mRNA in situ. With this Special Issue, the editors wanted to create a forum for the international biomedical research community to compile their data on the genetic complexity of cancer in a unique resource. While this collection of articles cannot certainly claim completeness in any way, it represents an attractive collection of the different aspects of hormone-dependent cancers and will hopefully encourage further targeted research.

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
palbociclib; estrogen receptor; breast cancer; CDK4/6; CDK4/6 inhibitors; therapy resistance; DNA repair; metabolic rewiring; quantitative proteomics; urothelial carcinoma; molecular subtypes; therapeutic target; prostate cancer; prognostic signature; diagnostic signature; biomarkers; cancer progression; aggressive cancer; androgen receptor; estrogen receptor; gene expression; insulin receptor; prostate cancer; prostate cancer; germline mutations; somatic mutations; PTEN; TMPRSS2; ERG; androgen receptors; cervical cancer; alternative splicing; biomarkers; SR proteins; hnRNP; drug resistance; head and neck squamous cell carcinoma (HNSCC); aberrant splicing events; human papillomavirus (HPV) infection; non-coding RNA (ncRNA); methylation; mutational burden; next-generation digital histopathology; tissue cytometry; multiplexing; RNA ISH; cancer; tumor immune microenvironment; tumor microenvironment; prostate cancer; IRX4; alternative splicing; transcript; isoforms; long non-coding RNA; prostate cancer; breast cancer; single nucleotide polymorphisms; genome-wide association studies